Stock ALC ALCON INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Alcon Inc.

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange
Other stock markets
 11:31:30 2024-04-26 am EDT 		5-day change 1st Jan Change
72 CHF +0.61% Intraday chart for Alcon Inc. -0.66% +9.69%
Mar. 26 Alcon Announces Management Changes CI
Mar. 26 Alcon’s Medical Chief to Retire; Successor Named MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27,799 33,104 43,290 33,588 38,457 38,825 - -
Enterprise Value (EV) 1 30,797 36,050 46,201 37,288 42,057 41,770 40,581 39,160
P/E ratio -42.2 x -61.2 x 116 x 100 x 39.8 x 43.2 x 33.3 x 30.6 x
Yield - 0.15% 0.24% 0.33% - 0.37% 0.44% 0.47%
Capitalization / Revenue 3.7 x 4.84 x 5.22 x 3.85 x 4.07 x 3.88 x 3.65 x 3.43 x
EV / Revenue 4.1 x 5.28 x 5.57 x 4.28 x 4.45 x 4.18 x 3.81 x 3.46 x
EV / EBITDA 18.3 x 31.6 x 25.7 x 20.8 x 18.1 x 16 x 13.9 x 12.2 x
EV / FCF 83.9 x 105 x 71.6 x 64.2 x 57.6 x 31.7 x 26.1 x 21 x
FCF Yield 1.19% 0.95% 1.4% 1.56% 1.74% 3.16% 3.83% 4.77%
Price to Book 1.43 x 1.73 x 2.25 x 1.71 x - 1.84 x 1.77 x 1.65 x
Nbr of stocks (in thousands) 491,700 496,300 490,100 491,700 493,200 493,244 - -
Reference price 2 56.54 66.70 88.33 68.31 77.97 78.71 78.71 78.71
Announcement Date 2/25/20 2/23/21 2/15/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,508 6,833 8,291 8,717 9,455 10,003 10,650 11,325
EBITDA 1 1,681 1,141 1,799 1,795 2,325 2,617 2,924 3,215
EBIT 1 1,265 789 1,443 1,571 1,849 2,095 2,368 2,632
Operating Margin 16.85% 11.55% 17.4% 18.02% 19.56% 20.94% 22.23% 23.24%
Earnings before Tax (EBT) 1 -332 -635 418 463 832 1,157 1,392 1,645
Net income 1 -656 -531 376 335 974 935.7 1,255 1,403
Net margin -8.74% -7.77% 4.54% 3.84% 10.3% 9.35% 11.78% 12.39%
EPS 2 -1.340 -1.090 0.7600 0.6800 1.960 1.821 2.365 2.572
Free Cash Flow 1 367 344 645 581 730 1,318 1,556 1,866
FCF margin 4.89% 5.03% 7.78% 6.67% 7.72% 13.18% 14.61% 16.48%
FCF Conversion (EBITDA) 21.83% 30.15% 35.85% 32.37% 31.4% 50.36% 53.21% 58.04%
FCF Conversion (Net income) - - 171.54% 173.43% 74.95% 140.85% 123.98% 133.03%
Dividend per Share 2 - 0.1000 0.2159 0.2239 - 0.2890 0.3473 0.3699
Announcement Date 2/25/20 2/23/21 2/15/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1
Net sales 1 3,055 2,102 2,149 2,189 2,200 2,140 2,171 2,352 2,422 4,774 2,329 2,352 2,467 2,557 5,043 2,482 2,501 4,979 2,600
EBITDA 1 - 451 440 549 503 467 297 590 591 - 566 568 627.2 642.2 1,266 654.1 689.9 1,313 720
EBIT 1 -323 369 348 448 405 365 353 480 479 959 450 440 503.3 515.4 1,017 519.9 559.5 1,064 577
Operating Margin -10.57% 17.55% 16.19% 20.47% 18.41% 17.06% 16.26% 20.41% 19.78% 20.09% 19.32% 18.71% 20.4% 20.15% 20.17% 20.95% 22.37% 21.37% 22.19%
Earnings before Tax (EBT) 1 - -23 141 200 147 147 -31 213 213 - 238 168 259.3 280.3 - 280 317 - 365.5
Net income 1 - 2 139 168 148 116 -97 174 169 343 204 427 210.3 219.8 487 226.5 252.7 522 292
Net margin - 0.1% 6.47% 7.67% 6.73% 5.42% -4.47% 7.4% 6.98% 7.18% 8.76% 18.15% 8.52% 8.6% 9.66% 9.13% 10.1% 10.48% 11.23%
EPS 2 - - 0.2800 0.3400 0.3000 0.2300 -0.2000 0.3500 0.3400 0.6900 0.4100 0.8600 0.4170 0.4348 0.9800 0.4420 0.4798 1.050 0.5850
Dividend per Share 2 - - 0.2159 - - - 0.2239 - - - - - - - - - 0.3073 - -
Announcement Date 8/18/20 11/9/21 2/15/22 5/10/22 8/9/22 11/15/22 2/27/23 5/9/23 8/15/23 8/15/23 11/14/23 2/27/24 - - - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,998 2,946 2,911 3,700 3,600 2,946 1,757 335
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.783 x 2.582 x 1.618 x 2.061 x 1.548 x 1.126 x 0.6008 x 0.1042 x
Free Cash Flow 1 367 344 645 581 730 1,318 1,556 1,866
ROE (net income / shareholders' equity) 4.41% 2.69% 5.58% 5.69% 4.83% 7.19% 8.03% 8.39%
ROA (Net income/ Total Assets) 3.38% 1.85% 3.82% 3.87% 3.31% 5.47% 5.44% 4.42%
Assets 1 -19,403 -28,653 9,833 8,648 29,390 17,092 23,054 31,756
Book Value Per Share 2 39.50 38.50 39.30 40.00 - 42.70 44.50 47.60
Cash Flow per Share 2 1.880 1.680 2.730 2.460 2.800 4.480 4.990 5.300
Capex 1 553 479 700 636 658 734 710 730
Capex / Sales 7.37% 7.01% 8.44% 7.3% 6.96% 7.33% 6.67% 6.44%
Announcement Date 2/25/20 2/23/21 2/15/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Alcon Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
78.71 USD
Average target price
93.32 USD
Spread / Average Target
+18.56%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
ALCON INC. Stock Alcon Inc.
+9.69% 38.82B
ESSILORLUXOTTICA Stock EssilorLuxottica
+11.95% 98.12B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-6.10% 17.66B
AUTEK CHINA INC. Stock Autek China Inc.
-20.02% 2.24B
WARBY PARKER INC. Stock Warby Parker Inc.
-8.37% 1.54B
PEGAVISION CORPORATION Stock Pegavision Corporation
+29.63% 1.23B
MENICON CO., LTD. Stock Menicon Co., Ltd.
-35.36% 735M
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-35.62% 747M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-13.36% 623M
VIZIONFOCUS INC. Stock Vizionfocus Inc.
+24.04% 494M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. ALC Stock
  4. Financials Alcon Inc.